Dogness Announces Retail Distribution Partnership With Xiuhu
Dogness Continues to Build Momentum in its Largest Revenue Markets
DONGGUAN, China, July 7, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company")
Raymond James Upgrades First Mid Bancshares to Outperform, Announces $45 Price Target
Raymond James analyst Daniel Tamayo upgrades First Mid Bancshares (NASDAQ:FMBH) from Market Perform to Outperform and announces $45 price target.
Raymond James Downgrades PacWest Banc to Market Perform
Raymond James analyst David Long downgrades PacWest Banc (NASDAQ:PACW) from Strong Buy to Market Perform.
Verve Therapeutics Amends Gene Editing Pact With Beam Therapeutics
Verve Therapeutics Inc (NASDAQ:VERV) entered into an Amended and Restated Collaboration and License Agreement with Beam Therapeutics Inc (NASDAQ:BEAM), which amended…
Raymond James Maintains Outperform on Azul, Lowers Price Target to $12
Raymond James analyst Savanthi Syth maintains Azul (NYSE:AZUL) with a Outperform and lowers the price target from $22 to $12.
Citigroup Maintains Buy on Spotify Technology, Lowers Price Target to $150
Citigroup analyst Jason Bazinet maintains Spotify Technology (NYSE:SPOT) with a Buy and lowers the price target from $165 to $150.
Raymond James Maintains Strong Buy on Huntington Bancshares, Lowers Price Target to $16
Raymond James analyst David Long maintains Huntington Bancshares (NASDAQ:HBAN) with a Strong Buy and lowers the price target from $18 to $16.
Raymond James Downgrades Horizon Bancorp to Outperform, Lowers Price Target to $22
Raymond James analyst David Long downgrades Horizon Bancorp (NASDAQ:HBNC) from Strong Buy to Outperform and lowers the price target from $23 to $22.
Kiromic BioPharma Announces Completion Of Expanded cGMP Manufacturing Facility To Support Cell Therapy Oncology Pipeline
Construction Completion is One of the Pre-requisites to Beginning the Deltacel™ Clinical Trial Activation Later This Year and Addresses a Key Clinical Hold Citation
Kiromic BioPharma, Inc. (NASDAQ:KRBP)
$1.4 Million Bet On This Healthcare Stock? 4 Penny Stocks Insiders are Buying
U.S. stock futures traded higher this morning on Thursday after closing slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades.